Investor
BIO-Europe Spring
The premier springtime partnering conference for the European biotechnology, biopharma, and digital medicine industries.
- When
- March, Late March
- Where
- RotatingView on Google Maps
- Format
- In person
- Organiser
- EBD Group
- Region
- Europe
- Scale
- About 3,500 attendees
- Founded
- 2007
The Signal
BIO-Europe Spring is a major regional partnering conference focused on life sciences, biopharma, and clinical assets. Organized by the EBD Group, the event utilizes a structured partnering system to facilitate thousands of private business meetings. While heavily biopharma focused, it increasingly features tracks on digital therapeutics, clinical trial software, and AI driven drug discovery. It is an essential venue for healthtech operators seeking to partner with pharmaceutical sponsors.
What to expect
- Biopharma licensing agreements
- Clinical trial technology partnerships
- Seed and Series A biotech funding rounds
- Drug discovery platform collaboration announcements
Who is in the room
Biotech executives, pharmaceutical business development teams, life science investors, and clinical research service providers attend.
Background
Created as a spring counterpart to the massive autumn BIO-Europe event, designed to maintain dealmaking momentum throughout the first half of the year. It rotates to a different European city each year.
Related events
Running this event, or spotted something out of date?